Jane Street Group, LLC Bluebird Bio, Inc. Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$4.07 - $10.6 $6,105 - $15,900	1,500 Added 5.56%	28,500 $138,000
Q4 2021 Feb 15, 2022	SELL	$8.96 - $16.31 $319,872 - $582,267	-35,700 Reduced 56.94%	27,000 $270,000
Q3 2021 Nov 16, 2021	SELL	$11.24 - $21.0 $579,984 - $1.08 Million	-51,600 Reduced 45.14%	62,700 $1.2 Million
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $604,340 - $740,015	-33,500 Reduced 22.67%	114,300 $3.66 Million
Q1 2021 May 18, 2021	BUY	$16.59 - $33.89 $995,400 - $2.03 Million	60,000 Added 68.34%	147,800 $4.46 Million
Q4 2020 Feb 17, 2021	BUY	$27.5 - $37.92 $96,250 - $132,720	3,500 Added 4.15%	87,800 $3.8 Million
Q3 2020 Nov 17, 2020	BUY	$34.44 - $43.75 $110,208 - $140,000	3,200 Added 3.95%	84,300 $4.55 Million
Q2 2020 Aug 17, 2020	BUY	$27.12 - $45.97 $1.67 Million - $2.83 Million	61,500 Added 313.78%	81,100 $4.95 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $2.49 Million - $6.05 Million	-95,300 Reduced 82.94%	19,600 $901,000
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $5.08 Million - $6.67 Million	108,100 Added 1589.71%	114,900 $10.1 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $1.8 Million - $2.81 Million	-30,200 Reduced 81.62%	6,800 $624,000
Q2 2019 Aug 15, 2019	SELL	$75.84 - $105.21 $113,760 - $157,815	-1,500 Reduced 3.9%	37,000 $4.71 Million
Q1 2019 May 16, 2019	BUY	$64.44 - $104.11 $1.6 Million - $2.58 Million	24,800 Added 181.02%	38,500 $6.06 Million
Q4 2018 Feb 15, 2019	BUY	$59.1 - $93.26 $29,550 - $46,630	500 Added 3.79%	13,700 $1.36 Million
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $1.86 Million - $2.46 Million	-20,900 Reduced 61.29%	13,200 $1.93 Million
Q2 2018 Aug 15, 2018	BUY	$99.64 - $127.59 $1.88 Million - $2.41 Million	18,900 Added 124.34%	34,100 $5.35 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $275,080 - $392,444	2,600 Added 20.63%	15,200 $2.6 Million
Q4 2017 Feb 15, 2018	SELL	$81.25 - $130.7 $2.85 Million - $4.59 Million	-35,100 Reduced 73.58%	12,600 $2.24 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $2.75 Million - $4.36 Million	47,700	47,700 $6.55 Million

Others Institutions Holding BLUE

# of Institutions

150

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$139 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$94.5 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$42.2 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$42.1 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$34.7 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $696M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account